EU Grants Conditional Approval for Danaher's Purchase of GE's Biopharma Business
The company will first have to sell five businesses for the merger to go ahead.
December 18, 2019 at 05:27 PM
2 minute read
The European Commission has cleared U.S. medical equipment-maker Danaher Corp to buy General Electric's healthcare life sciences biopharma business but with divestment conditions.
In February, Danaher said it wanted to buy the GE biopharma business for $21.4 billion – a deal it said would boost the company's presence in the biopharma industry and give it access to tools for research and development of drugs.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250